Essential Pharma and Clinigen Expand Collaboration to Improve Patient Access in JAPAC
Agreement drives continued patient access to four important therapies in Japan and Korea Strengthens Essential Pharma and Clinigen's combined market presence in the JAPAC region Egham, UK - 6th ...
Alligator Bioscience Successfully Completes End of Phase 2 Interaction with FDA For Mitazalimab
LUND, SE / ACCESS Newswire / February 6, 2025 / Alligator Bioscience (STO:ATORX)FDA feedback validates the clinical development strategy and Phase 3 designFDA feedback confirms that the toxicology pac ...